Skip to Main Content

For further information, see CMDT Part 9-06: Asthma

KEY FEATURES

Essentials of Diagnosis

  • Respiratory symptoms such as wheezing, dyspnea, or cough, which may be variable in time and severity

  • Variable limitation on expiratory airflow in pulmonary function testing (PFT) or positive bronchoprovocation challenge

General Considerations

  • A chronic disorder of the airways characterized by variable airway expiratory obstruction and hyperresponsiveness

  • Most common pathogeneses

    • Airway inflammation with eosinophils, neutrophils, and lymphocytes (especially T cells)

    • Goblet cell hyperplasia

    • Plugging of small airways with mucus

    • Collagen deposition beneath the basement membrane

    • Bronchial smooth muscle hypertrophy

    • Airway edema

    • Mast cell activation

    • Denudation of airway epithelium

  • The pathophysiology of asthma is heterogeneous, but a division into T2-high and T2-low endotypes (marked by high and low levels of classic Th2 cytokines, including IL-4, IL-5, and IL-13) has been shown to be important in the selection of targeted biologic therapies

    • T2-high asthma phenotypes include allergic asthma, late-onset T2-high asthma, and aspirin/NSAID-associated respiratory disease (AERD)

    • T2-low asthma phenotypes include nonallergic asthma, which tends to occur in adults and be marked by neutrophilic inflammation and variable response to standard therapies

  • Common aeroallergens

    • Dust mites

    • Cockroaches

    • Cat dander

    • Seasonal pollens

  • Nonspecific precipitants

    • Respiratory tract infections, especially viral

    • Rhinosinusitis

    • Postnasal drip

    • Aspiration

    • Gastroesophageal reflux

    • Changes in weather

    • Stress

    • Exercise

  • Asthma with persistent airflow limitation thought to be due to airway remodeling

  • Asthma with obesity refers to prominent respiratory symptoms in patients with obesity with little airway inflammation

  • Tobacco increases symptoms and decreases lung function

  • Certain medications (including aspirin and nonsteroidal anti-inflammatory drugs [NSAID]) may be triggers (Table 9–22)

Table 9–22.Pulmonary manifestations of selected medication toxicities.

Demographics

  • Affects 8–10% of the population in the United States

  • Accounts for 10 million office visits, 1.8 million emergency department visits, and more than 3500 deaths annually in the United States

  • Slightly more common in male children (< 14 years old) and in female adults

  • There is a genetic predisposition to asthma

  • Hospitalization rates have been highest among Black persons and children

  • Death rates for asthma are consistently highest among Black persons aged 15–24 years

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.

  • Create a Free Profile